Framework contract for supply of eltrombopag 25 mg tablets
Original notice title
Malta – Pharmaceutical products – CT2343/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF ELTROMBOPAG 25 MG TABLETS
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Department of Contracts
- Country
- Malta
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Dec 21, 2026
- Estimated value
- EUR 2M
AI tender analysis
Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.
Buyer
Location
Floriana, MLT
Website
Buyer profile
Identifier
MT25645419
Activity
General public services
Lots (1)
LOT-0001
CT2343/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF ELTROMBOPAG 25 MG TABLETS
CT2343/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF ELTROMBOPAG 25 MG TABLETS
EUR 2M
Estimated value
Location
Category
Award details
CT2343/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF ELTROMBOPAG 25 MG TABLETS
Procurement Details
- Publication date
- 19 Nov 2026
- Languages
- English
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 810334-2026
Documents (2)
Similar tenders
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Aflibercept, ausgenommen 114,3 mg/ml (ATC-Code: S01LA05).
Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
Poland – Pharmaceutical products – DOSTAWA LEKÓW – 98 CZĘŚCI
Poland – Pharmaceutical products – ZP/CZD/140/26 Dostawa produktów leczniczych – 4 pakiety.
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Erythropoietin (ATC-Code: B03XA01).
Lithuania – Pharmaceutical products – Medikamentai
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications